Barcelona telerehabilitation start-up Dycare targets Brazil after doubling revenue to €1.3 million

The story so far, in brief; the legwork, and the full article, stay with the original outlet.

Dycare was founded in 2015 by Silvia Raga, a biomedical engineer, and Ricardo Jáuregui, now its CTO, after both went through group physiotherapy for a shoulder and an ankle injury and could not get anyone to say how their progress was measured. The company was formally incorporated in 2016. In 2018 it began designing ReHub, a remote rehabilitation platform that uses image analysis and artificial intelligence instead of extra hardware. ReHub launched in 2021.

The pandemic made health systems more willing to try telemedicine. ReHub is now used by more than 100 hospitals and clinics, has run more than three million digital therapy sessions and treats 15,000 to 20,000 patients a year. Its public contracts include work with the health departments of the Basque Country, Aragón, Cantabria and Catalonia, and it built a fully digital physiotherapy service with DKV Seguros. Revenue was about €500,000 in 2024 and €1.3 million in 2025, and the company expects €2.5 million in 2026.

Dycare entered Colombia nearly three years ago and has since moved into Peru and Chile. Brazil is next. It holds medical device registrations from INVIMA in Colombia, ANVISA in Brazil and COFEPRIS in Mexico, as well as the CE MDR mark in Europe. Early on, the founders recall, clinicians saw the software as a competitor rather than a tool. "La IA está ahora de moda, pero nosotros llevamos muchísimos años investigando," they said. That sentence would have been a harder pitch in 2015.